Accord Healthcare Polska Sp. z o.o. Pharmadox Healthcare Ltd.

Poland

All drugs from this manufacturer

  • CLOFARABINE ACCORD

    The medicine is used to treat acute lymphoblastic leukemia (ALL) in children (from 1 year of age), adolescents, and young adults (up to 21 years) for whom previous therapies have not been effective or have ceased to work.

    Dosage form: solution for infusion, concentrate

    Active substance Dosage
    clofarabine 1 mg/ml

    ATC: L01BB06

  • FULVESTRANT ACCORD

    The medicine is used to treat postmenopausal women with a certain type of breast cancer (locally advanced or metastatic) that is hormone receptor-positive. It may also be used in combination with palbociclib in women with hormone receptor-positive breast cancer (without HER2 overexpression).

    Dosage form: solution for injection in ampoule-syringe

    Active substance Dosage
    fulvestrant 250 mg/5 ml

    ATC: L02BA03

  • NEVIRAPINE ACCORD

    The medicine is used to treat HIV-1 infections in adults, adolescents, and children over 3 years of age (of appropriate body weight) who are able to swallow tablets.

    Dosage form: tablets, prolonged release

    Active substance Dosage
    nevirapine 400 mg

    ATC: J05AG01

  • NEVIRAPINE ACCORD

    The medicine is used to treat HIV-1 infections in adults, adolescents, and children.

    Dosage form: tablets

    Active substance Dosage
    nevirapine 200 mg

    ATC: J05AG01